SOD is evaluated through history and physical examination, blood tests, and imaging studies and is confirmed using sphincter of Oddi manometry (SOM) and endoscopic retrograde cholangiopancreatography (ERCP). Initially, blood tests are typically drawn and include a complete metabolic panel to assess liver enzymes and pancreatic enzymes, such as amylase and lipase, to assess for pancreatitis. Sometimes in SOD, liver enzymes, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and bilirubin, will be elevated and indicate biliary tree and liver involvement. Pancreatic enzymes may also be elevated if the pancreas becomes significantly damaged; however, they may also be within normal limits even during episodes of pancreatitis.
Imaging studies such as an ultrasound or computed tomography (CT) scan may then be ordered to further evaluate the underlying cause. A CT may reveal common bile duct and/or pancreatic duct dilation. A magnetic resonance cholangiopancreatography (MRCP) may also be useful to visualize both the pancreatic and biliary ducts. Another nuclear imaging study, the hepatobiliary iminodiacetic (HIDA) scan may also be useful to evaluate the outflow of the biliary system. In addition, fatty meal sonography, which is an ultrasound taken before and after ingesting fatty foods, may also be used. This imaging study evaluates the response of the sphincter of Oddi to CCK, which is released after food intake. While the sensitivity of fatty meal sonography is 21%, the specificity is 97%.
Once initial imaging studies have been done, other methods may be used to confirm the diagnosis. A sphincter of Oddi manometry (SOM) is the gold standard to diagnose SOD and can be done during an endoscopic retrograde cholangiopancreatography (ERCP): a surgical procedure that allows the healthcare provider to visualize the sphincter of Oddi and surrounding structures using endoscopy and fluoroscopy. SOM uses a catheter to measure sphincter pressure. When the pressure is greater than 40 mmHg, a diagnosis of SOD can be made.
During the diagnostic process, the Milwaukee criteria may be utilized to determine the specific type of SOD that is present. Type I SOD occurs when an individual has
biliary pain, abnormal chemistries, and either a dilated CBD or pancreatic duct. Individuals with type II SOD have biliary pain and either an abnormal chemistry panel or dilated ducts. Finally, individuals with type III SOD have only biliary pain but with no indication of abnormal chemistries or dilated ducts. Type III SOD can be difficult to diagnose due to the absence of diagnostic findings.